This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: The Innovative Contributions of Makoto Tatsuzuki
Introduction
Makoto Tatsuzuki is a prominent inventor based in Toshima-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for various mental and physical health conditions. With a total of 3 patents to his name, Tatsuzuki's work is recognized for its potential impact on healthcare.
Latest Patents
Tatsuzuki's latest patents focus on phenylpyrazole derivatives, which serve as prophylactic or therapeutic agents for a range of disorders. These include dementia, Alzheimer's disease, attention-deficit hyperactivity disorder, schizophrenia, eating disorders, obesity, diabetes, hyperlipidemia, sleep disorders, narcolepsy, sleep apnea syndrome, circadian rhythm disorder, depression, and allergic rhinitis. The inventions provide a phenylpyrazole derivative represented by a specific formula, along with pharmaceutically acceptable salts, aimed at addressing these critical health issues.
Career Highlights
Makoto Tatsuzuki is currently associated with Taisho Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to improving patient outcomes through scientific research and development.
Collaborations
Tatsuzuki collaborates with notable colleagues, including Toshio Nakamura and Dai Nozawa, to advance their shared goals in pharmaceutical innovation. Their teamwork enhances the potential for groundbreaking discoveries in their field.
Conclusion
In summary, Makoto Tatsuzuki is a dedicated inventor whose work in phenylpyrazole derivatives holds promise for treating various health conditions. His contributions to Taisho Pharmaceutical Co., Ltd. and collaborations with esteemed colleagues underscore his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
